M. Kraus & Co
- SEC CIK
- 0001593688
- Latest filing
- Jul 29, 2026
TMO holding history
Thermo Fisher Scientific Inc. in every 13F filed by M. Kraus & Co, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
TMO overviewAll 13F holders of TMOFull Q2 2026 holdings
- Shares (Q2 2026)
- 29,510
- Value
- $14.8M
- % of portfolio
- 3.9%
- Quarters held
- 22
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 29,510 | $14.8M | 3.9% | −346−1.2% | Reduced | Holders |
| Q1 2026 | 29,856 | $14.7M | 4.3% | +176+0.6% | Added | Holders |
| Q4 2025 | 29,680 | $17.2M | 4.8% | −203−0.7% | Reduced | Holders |
| Q3 2025 | 29,883 | $14.5M | 4.0% | −1,194−3.8% | Reduced | Holders |
| Q2 2025 | 31,077 | $12.6M | 3.7% | −138−0.4% | Reduced | Holders |
| Q1 2025 | 31,215 | $15.5M | 4.7% | +20.0% | Added | Holders |
| Q4 2024 | 31,213 | $16.2M | 4.9% | −53−0.2% | Reduced | Holders |
| Q3 2024 | 31,266 | $19.3M | 5.7% | −708−2.2% | Reduced | Holders |
| Q2 2024 | 31,974 | $17.7M | 5.4% | −307−1.0% | Reduced | Holders |
| Q1 2024 | 32,281 | $18.8M | 5.7% | −988−3.0% | Reduced | Holders |
| Q4 2023 | 33,269 | $17.7M | 5.8% | +138+0.4% | Added | Holders |
| Q3 2023 | 33,131 | $16.8M | 6.0% | +113+0.3% | Added | Holders |
| Q2 2023 | 33,018 | $17.2M | 5.8% | −266−0.8% | Reduced | Holders |
| Q1 2023 | 33,284 | $19.2M | 6.8% | −408−1.2% | Reduced | Holders |
| Q4 2022 | 33,692 | $18.6M | 6.8% | +18+0.1% | Added | Holders |
| Q3 2022 | 33,674 | $17.1M | 7.2% | −89−0.3% | Reduced | Holders |
| Q2 2022 | 33,763 | $18.3M | 7.1% | −29−0.1% | Reduced | Holders |
| Q1 2022 | 33,792 | $20.0M | 6.7% | −1,169−3.3% | Reduced | Holders |
| Q4 2021 | 34,961 | $23.3M | 7.4% | −351−1.0% | Reduced | Holders |
| Q3 2021 | 35,312 | $20.2M | 7.2% | −285−0.8% | Reduced | Holders |
| Q2 2021 | 35,597 | $18.0M | 6.5% | −218−0.6% | Reduced | Holders |
| Q1 2021 | 35,815 | $16.3M | 6.3% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.